GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Price-to-Owner-Earnings

CGNSF (Cognetivity Neurosciences) Price-to-Owner-Earnings : (As of Sep. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Price-to-Owner-Earnings?

As of today (2024-09-25), Cognetivity Neurosciences's share price is $0.0187. Cognetivity Neurosciences does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Cognetivity Neurosciences's Price-to-Owner-Earnings or its related term are showing as below:


CGNSF's Price-to-Owner-Earnings is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 20.89
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-09-25), Cognetivity Neurosciences's share price is $0.0187. Cognetivity Neurosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.07. Therefore, Cognetivity Neurosciences's PE Ratio for today is At Loss.

As of today (2024-09-25), Cognetivity Neurosciences's share price is $0.0187. Cognetivity Neurosciences's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.08. Therefore, Cognetivity Neurosciences's PE Ratio without NRI for today is At Loss.


Cognetivity Neurosciences Price-to-Owner-Earnings Historical Data

The historical data trend for Cognetivity Neurosciences's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Price-to-Owner-Earnings Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cognetivity Neurosciences's Price-to-Owner-Earnings

For the Health Information Services subindustry, Cognetivity Neurosciences's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Price-to-Owner-Earnings Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Price-to-Owner-Earnings falls into.



Cognetivity Neurosciences Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cognetivity Neurosciences's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.0187/-0.08
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cognetivity Neurosciences  (OTCPK:CGNSF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Cognetivity Neurosciences Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences Headlines

From GuruFocus

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire 04-12-2019